Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 575; https://doi.org/10.3797/scipharm.cespt.8.LNT01 (registering DOI)
Important Parameters in Cytotoxicity Testing of Nanoparticles
Center for Medical Research, Medical University of Graz, Austria
Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Austria
Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens-University of Graz, Austria
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
PDF [150 KB, uploaded 30 September 2016]
Note: In lieu of an abstract, this is an excerpt from the first page.
: The use of nano-sized materials (NMs) offers exciting new options in technical and medical applications. Adverse effects on cells and organs, however, [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
MEINDL, C.; ROBLEGG, E.; PIEBER, T.R.; FRÖHLICH, E. Important Parameters in Cytotoxicity Testing of Nanoparticles. Sci. Pharm. 2010, 78, 575.
MEINDL C, ROBLEGG E, PIEBER TR, FRÖHLICH E. Important Parameters in Cytotoxicity Testing of Nanoparticles. Scientia Pharmaceutica. 2010; 78(3):575.
MEINDL, C.; ROBLEGG, E.; PIEBER, T. R.; FRÖHLICH, E. 2010. "Important Parameters in Cytotoxicity Testing of Nanoparticles." Sci. Pharm. 78, no. 3: 575.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.